120 related articles for article (PubMed ID: 33493533)
41. Ubiquitin-conjugating enzyme UBE2O regulates cellular clock function by promoting the degradation of the transcription factor BMAL1.
Chen S; Yang J; Zhang Y; Duan C; Liu Q; Huang Z; Xu Y; Zhou L; Xu G
J Biol Chem; 2018 Jul; 293(29):11296-11309. PubMed ID: 29871923
[TBL] [Abstract][Full Text] [Related]
42. Regulation of cytokine receptor signaling by SOCS1.
Ilangumaran S; Rottapel R
Immunol Rev; 2003 Apr; 192():196-211. PubMed ID: 12670405
[TBL] [Abstract][Full Text] [Related]
43. Suppressor of cytokine signaling 1 interacts with the macrophage colony-stimulating factor receptor and negatively regulates its proliferation signal.
Bourette RP; De Sepulveda P; Arnaud S; Dubreuil P; Rottapel R; Mouchiroud G
J Biol Chem; 2001 Jun; 276(25):22133-9. PubMed ID: 11297560
[TBL] [Abstract][Full Text] [Related]
44. CUEDC2, a novel interacting partner of the SOCS1 protein, plays important roles in the leukaemogenesis of acute myeloid leukaemia.
Wu QY; Zhu YY; Liu Y; Wei F; Tong YX; Cao J; Zhou P; Niu MS; Li ZY; Zeng LY; Li F; Xu KL
Cell Death Dis; 2018 Jul; 9(7):774. PubMed ID: 29991678
[TBL] [Abstract][Full Text] [Related]
45. SOCS1 and its Potential Clinical Role in Tumor.
Ying J; Qiu X; Lu Y; Zhang M
Pathol Oncol Res; 2019 Oct; 25(4):1295-1301. PubMed ID: 30761449
[TBL] [Abstract][Full Text] [Related]
46. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
[TBL] [Abstract][Full Text] [Related]
47. SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment.
Demirel Ö; Balló O; Reddy PNG; Vakhrusheva O; Zhang J; Eichler A; Fernandes R; Badura S; Serve H; Brandts C
PLoS One; 2017; 12(7):e0180401. PubMed ID: 28753604
[TBL] [Abstract][Full Text] [Related]
48. Accumulation of p53 via down-regulation of UBE2D family genes is a critical pathway for cadmium-induced renal toxicity.
Lee JY; Tokumoto M; Fujiwara Y; Hasegawa T; Seko Y; Shimada A; Satoh M
Sci Rep; 2016 Feb; 6():21968. PubMed ID: 26912277
[TBL] [Abstract][Full Text] [Related]
49. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
[TBL] [Abstract][Full Text] [Related]
50. SOCS1 Represses Fractionated Ionizing Radiation-Induced EMT Signaling Pathways through the Counter-Regulation of ROS-Scavenging and ROS-Generating Systems.
Kim S; Kim SH; Lee CE
Cell Physiol Biochem; 2020 Oct; 54(5):1026-1040. PubMed ID: 33048478
[TBL] [Abstract][Full Text] [Related]
51. c-Src kinase activity is required for hepatocyte growth factor-induced motility and anchorage-independent growth of mammary carcinoma cells.
Rahimi N; Hung W; Tremblay E; Saulnier R; Elliott B
J Biol Chem; 1998 Dec; 273(50):33714-21. PubMed ID: 9837958
[TBL] [Abstract][Full Text] [Related]
52. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
53. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
[TBL] [Abstract][Full Text] [Related]
54. Inorganic arsenic induces apoptosis through downregulation of Ube2d genes and p53 accumulation in rat proximal tubular cells.
Tokumoto M; Lee JY; Fujiwara Y; Uchiyama M; Satoh M
J Toxicol Sci; 2013; 38(6):815-20. PubMed ID: 24212999
[TBL] [Abstract][Full Text] [Related]
55. Cbl interacts with multiple E2s in vitro and in cells.
Liyasova MS; Ma K; Voeller D; Ryan PE; Chen J; Klevit RE; Lipkowitz S
PLoS One; 2019; 14(5):e0216967. PubMed ID: 31120930
[TBL] [Abstract][Full Text] [Related]
56. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
57. Disproportionately high levels of HGF induce the degradation of the c-met receptor through the proteasomal degradation pathway.
Lee N; Lee J; Lee SH; Kim S; Kim S
Biochem Biophys Res Commun; 2018 Nov; 505(3):925-930. PubMed ID: 30309648
[TBL] [Abstract][Full Text] [Related]
58. Hepatocyte growth control by SOCS1 and SOCS3.
Khan MGM; Ghosh A; Variya B; Santharam MA; Kandhi R; Ramanathan S; Ilangumaran S
Cytokine; 2019 Sep; 121():154733. PubMed ID: 31154249
[TBL] [Abstract][Full Text] [Related]
59. Characterization and function of an E2-17 kDa (UBE2D) in an invertebrate Haliotis diversicolor supertexta.
Ye S; Wu L; Luo M; Xu T; Wu X
Fish Shellfish Immunol; 2013 Jun; 34(6):1496-504. PubMed ID: 23542885
[TBL] [Abstract][Full Text] [Related]
60. JAB/SOCS1/SSI-1 is an interleukin-2-induced inhibitor of IL-2 signaling.
Sporri B; Kovanen PE; Sasaki A; Yoshimura A; Leonard WJ
Blood; 2001 Jan; 97(1):221-6. PubMed ID: 11133764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
